title: [Smokeless tobacco and cardiovascular risk].
abstract: The use of "snus" (smokeless tobacco) can be detrimental to health. Snus delivers rapidly high doses of nicotine which can lead to addiction. The use of snus increases the risk of myocardial infarction and stroke. Nicotine substitution therapy as well as bupropion and varenicline reduce withdrawal symptoms and tobacco craving during snus cessation. However, they have been shown not to assist in long-term abstinence. Information concerning potential cardiovascular hazards of snus must be incorporated into health educational programs in order to discourage its use. Snus is not a recommended product to help stop smoking.
authors.affiliation: Unité de tabacologie, service de pneumologie, pôle tronc-greffes-vaisseaux, CHU de Poitiers, France. m.underner@chu-poitiers.fr
authors.forename: M
authors.initials: M
authors.lastname: Underner
authors.forename: J
authors.initials: J
authors.lastname: Perriot
authors.forename: P
authors.initials: P
authors.lastname: Sosner
authors.forename: D
authors.initials: D
authors.lastname: Herpin
mesh_terms: D006801:Humans; D009203:Myocardial Infarction / Q000209:etiology*; D009538:Nicotine / Q000009:adverse effects / Q000032:analysis; D058226:Plaque, Atherosclerotic / Q000209:etiology; D020521:Stroke / Q000209:etiology*; D061485:Tobacco Use Cessation Devices; D014030:Tobacco, Smokeless / Q000009:adverse effects* / Q000737:chemistry
chemical_list: D009538:Nicotine